Exelixis, Inc. (EXEL)
41.82
+0.75
(+1.83%)
USD |
NASDAQ |
Mar 17, 16:00
41.82
0.00 (0.00%)
After-Hours: 19:08
Exelixis Profit Margin (Quarterly) : 40.85% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Natera, Inc. | 7.10% |
| Merck & Co., Inc. | 18.15% |
| Castle Biosciences, Inc. | -2.68% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Bio-Techne Corp. | 12.84% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 36.46% |
| Return on Assets | 27.54% |
| Return on Invested Capital | 33.47% |
| Gross Profit Margin (Quarterly) | 95.58% |
| Operating Margin (Quarterly) | 39.41% |
| Return on Net Operating Assets | 142.1% |